HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G Bostwick Selected Research

Prostatic Intraepithelial Neoplasia

10/2009Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
12/2007Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.
9/2007Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
7/2006Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
6/2005Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.
8/2004Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia.
2/2004Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
1/2004High-grade prostatic intraepithelial neoplasia.
9/2003Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6.
1/2003Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G Bostwick Research Topics

Disease

36Neoplasms (Cancer)
08/2014 - 01/2002
35Prostatic Neoplasms (Prostate Cancer)
11/2015 - 09/2002
12Adenocarcinoma
10/2009 - 09/2002
10Prostatic Intraepithelial Neoplasia
10/2009 - 01/2003
9Carcinoma (Carcinomatosis)
03/2014 - 01/2002
5Hyperplasia
04/2010 - 01/2003
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2010 - 01/2003
3Margins of Excision
10/2008 - 06/2005
3Necrosis
12/2004 - 11/2003
3Carcinogenesis
11/2004 - 02/2004
2Aneuploidy (Aneuploid)
04/2010 - 10/2007
2Pain (Aches)
09/2007 - 09/2003
2Phyllodes Tumor (Cystosarcoma Phylloides)
02/2007 - 10/2004
1Bacterial Vaginosis
05/2016
1Polyomavirus Infections
03/2014
1Melanoma (Melanoma, Malignant)
10/2011
1Nevus (Nevi)
10/2011
1Endometrial Neoplasms (Endometrial Cancer)
04/2010
1Urinary Retention
04/2010
1Heart Failure
04/2010
1Postmenopausal Osteoporosis
10/2009
1Hematuria
09/2009
1Pelvic Pain
09/2007
1Inflammation (Inflammations)
09/2007
1Prostatitis
09/2007
1Oxyphilic Adenoma (Oncocytoma)
08/2007
1Phyllodes Tumor of the Prostate
02/2007
1Hypogonadism (Hypergonadotropic Hypogonadism)
11/2006
1Urethral Neoplasms (Urethral Cancer)
05/2006
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2005
1Cystitis
12/2004
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2004

Drug/Important Bio-Agent (IBA)

9Prostate-Specific Antigen (Semenogelase)IBA
11/2015 - 01/2004
9Dutasteride (Avodart)FDA Link
11/2015 - 01/2005
8AndrogensIBA
01/2012 - 01/2003
7Keratins (Keratin)IBA
10/2009 - 07/2003
6SeleniumIBA
09/2013 - 02/2003
5DNA (Deoxyribonucleic Acid)IBA
09/2013 - 09/2002
5Biomarkers (Surrogate Marker)IBA
03/2010 - 10/2004
4ParaffinIBA
04/2005 - 01/2003
3Hematoxylin (Haematoxylon)IBA
03/2014 - 09/2003
3ChromatinIBA
11/2008 - 09/2003
3Androgen Receptors (Androgen Receptor)IBA
10/2008 - 11/2006
3VimentinIBA
10/2008 - 09/2004
3ChromograninsIBA
05/2005 - 09/2002
3Biological ProductsIBA
05/2005 - 12/2003
3Formaldehyde (Formol)FDA Link
04/2005 - 10/2004
2EnzymesIBA
09/2013 - 06/2007
2Selenomethionine (Sethotope)FDA Link
11/2012 - 02/2003
2Vitamin EFDA LinkGeneric
11/2012 - 12/2009
2Testosterone (Sustanon)FDA Link
11/2012 - 11/2006
2Glutathione Transferase (Glutathione S-Transferase)IBA
09/2007 - 06/2007
2Proteins (Proteins, Gene)FDA Link
08/2007 - 02/2007
2Phenobarbital (Luminal)FDA Link
02/2007 - 09/2004
2Trace Elements (Biometals)IBA
07/2005 - 02/2003
2prostatic acid phosphataseIBA
05/2005 - 09/2004
2Hormones (Hormone)IBA
11/2004 - 09/2003
2Eosine Yellowish-(YS) (Eosin)IBA
08/2004 - 09/2003
1Pharmaceutical PreparationsIBA
05/2016
1AcidsIBA
03/2014
1Coloring Agents (Dyes)IBA
03/2014
1AntioxidantsIBA
09/2013
1methylselenic acidIBA
09/2013
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2013
1Oxidants (Oxidizing Agents)IBA
09/2013
1Dihydrotestosterone (Androstanolone)IBA
11/2012
1DNA ProbesIBA
10/2011
1Troleandomycin (TAO)FDA Link
04/2010
1Cathepsin BIBA
03/2010
1Racemases and Epimerases (Epimerases and Racemases)IBA
10/2009
1Protein Isoforms (Isoforms)IBA
10/2009
1IsoflavonesIBA
10/2009
1dimemorfan (AT 17)IBA
10/2009
1DesminIBA
10/2008
1AntigensIBA
01/2008
1IsoenzymesIBA
09/2007
1Epithelial Cell Adhesion MoleculeIBA
08/2007
1glutathione S-transferase alphaIBA
08/2007
1Keratin-7 (Cytokeratin 7)IBA
08/2007
1Glutathione S-Transferase piIBA
06/2007
1ErbB Receptors (EGF Receptor)IBA
02/2007
1Androgen Antagonists (Antiandrogens)IBA
02/2007
1ClusterinIBA
11/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2006
1Flutamide (Eulexin)FDA LinkGeneric
07/2006
1Fluconazole (Zonal)FDA LinkGeneric
05/2006
1Antineoplastic Agents (Antineoplastics)IBA
07/2005
1Mucin-1 (CA 15-3 Antigen)IBA
05/2005
1Oxygen (Dioxygen)IBA
12/2004

Therapy/Procedure

18Therapeutics
01/2012 - 01/2003
17Prostatectomy (Retropubic Prostatectomy)
08/2014 - 01/2002
5Radiotherapy
01/2012 - 01/2003
4Chemoprevention
09/2007 - 03/2004
2Cryotherapy (Therapy, Cold)
06/2008 - 02/2004
2Lasers (Laser)
10/2004 - 02/2002
2Lymph Node Excision (Lymph Node Dissection)
09/2002 - 01/2002
1Organ Transplantation
03/2014
1Indwelling Catheters (Indwelling Catheter)
09/2009
1Conservative Treatment
09/2009
1Aftercare (After-Treatment)
11/2004